中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [7]
上海药物研究所 [2]
自动化研究所 [2]
化学研究所 [1]
采集方式
OAI收割 [12]
内容类型
期刊论文 [12]
发表日期
2023 [1]
2022 [4]
2021 [4]
2016 [1]
2014 [1]
2010 [1]
更多
学科主题
筛选
浏览/检索结果:
共12条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer
期刊论文
OAI收割
JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 12, 页码: 2315-2328
作者:
Luo, LingJie
;
Lin, Caiji
;
Wang, Pengfei
;
Cao, Danli
;
Lin, Yiru
  |  
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2023/10/17
Immune checkpoint inhibitor
Phytochemicals
Combination therapy
Immune-related adverse events
Predictive biomarker
Gut microbiota
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
期刊论文
OAI收割
CANCER MEDICINE, 2022
作者:
Hao, Yue
;
Lin, Gen
;
Xiang, Jing
;
Wang, Wenxian
;
Xu, Chunwei
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/12/23
efficacy
immune-related adverse events
immunotherapy
thymoma
One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis
期刊论文
OAI收割
Cardiovascular Diabetology, 2022, 卷号: 21, 期号: 1, 页码: 10
作者:
Wang,Hong
;
Xie,Xiaoya
;
Zu,Quannan
;
Lu,Ming
;
Chen,Rongfa
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2022/11/14
Diabetes mellitus
Polymer-free Amphilimus-eluting stents
Durable polymer zotarolimus-eluting stents
Percutaneous coronary intervention
Cardiovascular outcomes
Target lesion failure
Major adverse cardiac events
Stent thrombosis
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
OAI收割
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
Image classification of immune checkpoint inhibitor-related pneumonia in lung cancer patients
期刊论文
OAI收割
CLINICAL IMAGING, 2022, 卷号: 86
作者:
Sun, Xiaojun
;
Song, Zhengbo
;
Jiang, Hongyang
;
Ma, Yanqing
;
Chen, Ming
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/12/23
Immune checkpoint inhibitor (ICI)
Immune-related adverse events
Immune checkpoint inhibitor-related & nbsp
Lung cancer
Image classification
pneumonia (ICIP)
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China
期刊论文
OAI收割
THORACIC CANCER, 2021
作者:
Shi, Yuequan
;
Fang, Jian
;
Zhou, Chengzhi
;
Liu, Anwen
;
Wang, Yan
  |  
收藏
  |  
浏览/下载:94/0
  |  
提交时间:2022/01/25
advanced lung cancer
immune checkpoint inhibitors
immune-related adverse events
real-world data
Application of Artificial Intelligence in Acute Coronary Syndrome: A Brief Literature Review
期刊论文
OAI收割
ADVANCES IN THERAPY, 2021, 页码: 9
作者:
Wang, Hong
;
Zu, Quannan
;
Chen, Jinglu
;
Yang, Zhiren
;
Ahmed, Mohammad Anis
  |  
收藏
  |  
浏览/下载:48/0
  |  
提交时间:2021/11/04
Artificial intelligence
Machine learning
Acute coronary syndrome
Percutaneous coronary intervention
Mortality
Myocardial infarction
Major adverse cardiac events
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens
期刊论文
OAI收割
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021
作者:
Cao, Fei
;
Zheng, Jiaping
;
Luo, Jun
;
Zhang, Zhewei
;
Shao, Guoliang
  |  
收藏
  |  
浏览/下载:62/0
  |  
提交时间:2021/08/30
Regorafenib plus DEB-TACE
CRLM
Treatment response
Prognosis
Adverse events
Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies
期刊论文
OAI收割
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021
作者:
Wang, Zeng
;
Jiang, Liyu
;
Yan, Hao
;
Xu, Zhifei
;
Luo, Peihua
  |  
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2021/04/26
Adverse events
chronic myeloid leukemia
management
mechanisms
molecular target
nilotinib
Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
期刊论文
OAI收割
MEDICINE, 2016, 卷号: 95, 期号: 38
作者:
Zhang, Haijun
;
Wang, Xiangfei
;
Deng, Wei
;
Wang, Shenguo
;
Ge, Junbo
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2017/01/11
abluminal biodegradable polymer
late lumen loss
major adverse cardiovascular events
sirolimus-eluting stent